These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 21886971)
1. Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders. Jha V; Kher V; Pisharody R; Sharma RK; Abraham G; Gokulnath ; Almeida A; Gupta A Indian J Nephrol; 2011 Jul; 21(3):143-51. PubMed ID: 21886971 [TBL] [Abstract][Full Text] [Related]
2. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764 [TBL] [Abstract][Full Text] [Related]
3. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541 [TBL] [Abstract][Full Text] [Related]
4. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries. Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA; Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398 [TBL] [Abstract][Full Text] [Related]
5. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD. Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166 [TBL] [Abstract][Full Text] [Related]
6. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050 [TBL] [Abstract][Full Text] [Related]
7. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Goldsmith DJ; Covic A; Fouque D; Locatelli F; Olgaard K; Rodriguez M; Spasovski G; Urena P; Zoccali C; London GM; Vanholder R Nephrol Dial Transplant; 2010 Dec; 25(12):3823-31. PubMed ID: 20829401 [TBL] [Abstract][Full Text] [Related]
8. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Holden RM; Mustafa RA; Alexander RT; Battistella M; Bevilacqua MU; Knoll G; Mac-Way F; Reslerova M; Wald R; Acott PD; Feltmate P; Grill A; Jindal KK; Karsanji M; Kiberd BA; Mahdavi S; McCarron K; Molnar AO; Pinsk M; Rodd C; Soroka SD; Vinson AJ; Zimmerman D; Clase CM Can J Kidney Health Dis; 2020; 7():2054358120944271. PubMed ID: 32821415 [TBL] [Abstract][Full Text] [Related]
9. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report. Wang AY; Akizawa T; Bavanandan S; Hamano T; Liew A; Lu KC; Lumlertgul D; Oh KH; Zhao MH; Ka-Shun Fung S; Obi Y; Sumida K; Choong LHL; Goh BL; Hao CM; Kwon YJ; Tarng DC; Zuo L; Wheeler DC; Tsukamoto Y; Fukagawa M Kidney Int Rep; 2019 Nov; 4(11):1523-1537. PubMed ID: 31890994 [TBL] [Abstract][Full Text] [Related]
10. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD. Drawz PE; Beddhu S; Bignall ONR; Cohen JB; Flynn JT; Ku E; Rahman M; Thomas G; Weir MR; Whelton PK Am J Kidney Dis; 2022 Mar; 79(3):311-327. PubMed ID: 35063302 [TBL] [Abstract][Full Text] [Related]
11. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD. Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines. Morrone LF; Russo D; Di Iorio B Int J Nephrol; 2011; 2011():958798. PubMed ID: 21603118 [TBL] [Abstract][Full Text] [Related]
13. KDOQI US Commentary on the 2020 KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Puttarajappa CM; Schinstock CA; Wu CM; Leca N; Kumar V; Vasudev BS; Hariharan S Am J Kidney Dis; 2021 Jun; 77(6):833-856. PubMed ID: 33745779 [TBL] [Abstract][Full Text] [Related]
14. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group Kidney Int Suppl; 2009 Aug; (113):S1-130. PubMed ID: 19644521 [TBL] [Abstract][Full Text] [Related]
15. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Mandelbrot DA; Reese PP; Garg N; Thomas CP; Rodrigue JR; Schinstock C; Doshi M; Cooper M; Friedewald J; Naik AS; Kaul DR; Ison MG; Rocco MV; Verbesey J; Hladunewich MA; Ibrahim HN; Poggio ED Am J Kidney Dis; 2020 Mar; 75(3):299-316. PubMed ID: 32007233 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes. Chuang SH; Wong HC; Vathsala A; Lee E; How PP Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726 [TBL] [Abstract][Full Text] [Related]
17. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults. Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ; Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678 [TBL] [Abstract][Full Text] [Related]
18. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C. Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907 [TBL] [Abstract][Full Text] [Related]
19. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Ketteler M; Block GA; Evenepoel P; Fukagawa M; Herzog CA; McCann L; Moe SM; Shroff R; Tonelli MA; Toussaint ND; Vervloet MG; Leonard MB Kidney Int; 2017 Jul; 92(1):26-36. PubMed ID: 28646995 [TBL] [Abstract][Full Text] [Related]
20. Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices. Fusaro M; Barbuto S; Gallieni M; Cossettini A; Re Sartò GV; Cosmai L; Cianciolo G; La Manna G; Nickolas T; Ferrari S; Bover J; Haarhaus M; Marino C; Mereu MC; Ravera M; Plebani M; Zaninotto M; Cozzolino M; Bianchi S; Messa P; Gregorini M; Gasperoni L; Agosto C; Aghi A; Tripepi G Clin Kidney J; 2024 Jan; 17(1):sfad290. PubMed ID: 38223338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]